Highest-scoring questions on the site.
Numbers first: 10 mg · sixteen weeks · injection-site erythema. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would…
The specifics, since they change the answer: survodutide · Changsha. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will…
What I am working with: 5 mg · 1 mL. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and it…
Setup, so nobody has to ask: a formic acid mobile phase · cagrilintide · a wide-pore C18 column. The empirical answer seems settled. The explanation does not. If the…
The case in front of me: Shanghai · Japan. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Stated plainly: TSH · dulaglutide. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Stated plainly: 98.8% · Medutest · 98.4%. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not discarded anything…
My background is chemistry rather than physiology, which may explain where I am stuck. These are treated as interchangeable and I do not think they are. If both are…
Details up front: hydrolysis · orforglipron · VendorInvestigate. I would like to understand the steps well enough to explain them to someone else. I have access to a…
Details up front: retatrutide · tirzepatide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
Conditions: reflux · dulaglutide. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would still…
I sent two vials from two different batches, both labelled 10 mg semaglutide, for independent testing and asked for purity and quantification on each. The results…
Details up front: a GLP-1 receptor agonist · SURMOUNT-4. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like…
Setup, so nobody has to ask: Xianning · Australia. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
What I am working with: tirzepatide · forty-two days. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that…
Details up front: mazdutide · 10 mg/mL. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
What I have: a GLP-1 receptor agonist · 2–8 °C. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I…
Setup, so nobody has to ask: SUSTAIN-6 · vomiting. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
For reference: 15 mg · ten weeks · injection-site erythema. I understand the observation; what I do not understand is the mechanism behind it. I have read the two…
The US labelling for several drugs in this class carries a boxed warning about thyroid C-cell tumours, and it is stated fairly starkly — tumours in both rats and…
Concretely: TSH · magnesium · oral semaglutide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Down 18% of body weight over ten months. My triglycerides have collapsed from 3.1 to 1.1 mmol/L, which is the change everyone predicted. My LDL-C has gone from 3.4 to…
What I have: 0.5 mg · dulaglutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
The case in front of me: 1 mg/mL · oral semaglutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…